EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Handshake on blue background

Lundbeck to acquire Longboard and potential blockbuster epilepsy drug

Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.
contract

Thomas J. Fuchs appointed as Lilly's first Chief AI Officer

Eli Lilly and Company appoints their first Chief AI Officer in Thomas J. Fuchs, to spearhead the strategic direction and leadership of AI.
The word spotlight on a blue background

Spotlight: September 2024

Catch up on all the biggest news to hit the pharmaceutical industry this September, including new appointments, mergers and acquisitions, approvals and more.
Doctors in a surgery room standing in a line

Lord Darzi’s report on the NHS: What pharma needs to know

For the pharmaceutical industry, this situation highlights ways to step in as partners in healthcare innovation and support the NHS during a turbulent time.

US scientists win Nobel Prize for Medicine for discovering microRNA

American researchers Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering discovery of microRNA.
world in hands

Gilead expands access to PrEP HIV candidate in 120 countries

A new licensing agreement from Gilead Sciences and six generic drug manufacturers is poised to transform HIV prevention efforts
Coin stacks

Genentech acquires Regor’s next-gen CKD inhibitor portfolio

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth $850M.
Orange lungs on yellow background

Sanofi and Regeneron's allergy drug is first biologic for COPD

Sanofi and Regeneron have announced that dupilumab has received an FDA approval in COPD and an eosinophilic phenotype.